PRESS RELEASE published on 08/12/2025 at 07:30, 1 year 2 months ago Mutares increases Holding net income by 32% to just under EUR 70 million in the first half of 2025 – More exit activity expected for the rest of the year Mutares Holding reports 32% increase in net income to just under EUR 70 million in the first half of 2025. Group revenue rises by 19% to EUR 3,106.3 million. More exit activity expected, confirming forecast for fiscal year 2025 Revenue Increase Net Income Forecast Mutares Holding Exit Activity
PRESS RELEASE published on 08/12/2025 at 07:30, 1 year 2 months ago DATAGROUP posts revenue growth in the third quarter and first nine months of 2024/2025 DATAGROUP SE reports revenue growth in Q3 & first nine months 2024/2025. EBIT margin at 8.0%. Orders from new customers and cross-selling contracts secured Revenue Growth EBIT Margin DATAGROUP SE New Customers Q3
PRESS RELEASE published on 08/12/2025 at 07:02, 1 year 2 months ago NORMA Group closes second quarter 2025 with stable profitability NORMA Group closes second quarter 2025 with stable profitability despite challenging market environment. Full-year forecast confirmed. Transformation to a focused industrial supplier by 2028 Business Development Profitability Full-year Forecast NORMA Group Industrial Supplier
PRESS RELEASE published on 08/12/2025 at 07:00, 1 year 2 months ago Focus on sustainable profitability: Komax Group reduces costs considerably Komax Group achieves sustainable profitability by reducing costs considerably amid market challenges. Positive EBIT and cost savings of CHF 25 million confirmed in 2025 half-year results Market Challenges EBIT Cost Reduction Komax Group Sustainable Profitability
PRESS RELEASE published on 08/12/2025 at 07:00, 1 year 2 months ago Sonova expands Infinio range and enters new market segment with Phonak’s smallest and first rechargeable in-the-ear hearing aid Sonova expands Infinio range with Phonak's smallest rechargeable in-the-ear hearing aid, Phonak Virto R Infinio. The launch marks an important step in entering the market segment Sonova Hearing Aid Phonak Infinio Rechargeable
PRESS RELEASE published on 08/12/2025 at 07:00, 1 year 2 months ago LLB successfully concludes share repurchase programme Liechtensteinische Landesbank AG successfully concludes share repurchase programme holding 1.4% of share capital Share Repurchase Capital Structure Liechtensteinische Landesbank LLB Treasury Management
PRESS RELEASE published on 08/12/2025 at 07:00, 1 year 2 months ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
PRESS RELEASE published on 08/12/2025 at 07:00, 1 year 2 months ago Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals initiates Phase III ENIGMA-TRS program with evenamide as add-on therapy for treatment-resistant schizophrenia patients, targeting TRS population Newron Pharmaceuticals Evenamide Phase III Treatment-resistant Schizophrenia ENIGMA-TRS Program
PRESS RELEASE published on 08/12/2025 at 07:00, 1 year 2 months ago Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates Valneva SE reports €97.6 million revenues in H1 2025, confirms 2025 financial outlook. Highlights financial results, R&D progress, and commercial updates Revenues Financial Results Valneva SE R&D Progress 2025 Outlook Commercial Updates
PRESS RELEASE published on 08/12/2025 at 06:55, 1 year 2 months ago PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian site, 2025 full-year guidance revised towards the upper end of the range PolyPeptide Group reports +24% revenue growth in H1 2025, revises full-year guidance towards upper range. EBITDA improved to EUR 4.4 million, major investments in capacity expansion projects EBITDA Revenue Growth Capacity Expansion PolyPeptide Group Full-year Guidance
Published on 11/06/2026 at 22:15, 21 hours 40 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 1 day 6 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 1 day 7 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 1 day 7 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/07/2026 at 13:35, 6 hours 20 minutes ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 23 hours 40 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 1 day ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 1 day ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 1 day 1 hour ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 17:54, 1 day 2 hours ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 1 day 2 hours ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026